NCT00792714View on ClinicalTrials.gov

Pharmacokinetics of Inhaled Mannitol in Cystic Fibrosis Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Cystic Fibrosis
Interventions
DRUG

Mannitol

400mg twice daily for 7 days

Trial Locations (4)

3052

Royal Children's Hospital, Melbourne

4101

Mater Adult Hospital, Brisbane

S102TH

Sheffield Children's Clinical Foundation, Sheffield

SO166YD

Southampton General Hospital, Southampton

Sponsors

Lead Sponsor

Syntara
All Listed Sponsors
lead

Syntara

INDUSTRY

NCT00792714 - Pharmacokinetics of Inhaled Mannitol in Cystic Fibrosis Patients | Biotech Hunter | Biotech Hunter